Metraipolis › archive › dc_bb9898cec546
ZMapp — Wikipedia (en)
- Source
- Wikipedia (en)
- Original
- https://en.wikipedia.org/wiki/ZMapp
- License (as archived)
- CC-BY-SA-4.0
- Archived
- 2026-10-08T00:01:10.345Z
- SHA-256 of the archived text
85729c4713cafa5cbd9536544f17d4c224373211ff994027159693751b862b95- Stable URL of this page
https://metraipolis.com/documento/dc_bb9898cec546
How to cite
ZMapp — Wikipedia (en) — Wikipedia (en), https://en.wikipedia.org/wiki/ZMapp (CC-BY-SA-4.0); archived copy: https://metraipolis.com/documento/dc_bb9898cec546 (Metraipolis archive dc_bb9898cec546, sha256 85729c4713cafa5cbd9536544f17d4c224373211ff994027159693751b862b95)
BibTeX
@misc{dcbb9898cec546,
title = {ZMapp — Wikipedia (en)},
howpublished = {Wikipedia (en)},
url = {https://en.wikipedia.org/wiki/ZMapp},
note = {License CC-BY-SA-4.0; archived copy https://metraipolis.com/documento/dc_bb9898cec546; sha256 85729c4713cafa5cbd9536544f17d4c224373211ff994027159693751b862b95},
year = {2026}
}Archived text
Reproduced under CC-BY-SA-4.0. Attribution: Wikipedia (en), https://en.wikipedia.org/wiki/ZMapp. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
ZMapp is an experimental biopharmaceutical medication comprising three chimeric monoclonal antibodies under development as a treatment for Ebola virus disease. Two of the three components were originally developed at the Public Health Agency of Canada's National Microbiology Laboratory (NML), and the third at the U.S. Army Medical Research Institute of Infectious Diseases; the cocktail was optimized by Gary Kobinger, a research scientist at the NML and underwent further development under license by Mapp Biopharmaceutical. ZMapp was first used on humans during the Western African Ebola virus epidemic, having only been previously tested on animals and not yet subjected to a randomized controlled trial. The National Institutes of Health (NIH) ran a clinical trial starting in January 2015 with 72 subjects from Sierra Leone, Guinea, and Liberia. It had aimed to enroll 200 people, but the epidemic waned and the trial closed early, leaving it too statistically underpowered to give a meaningful result about whether ZMapp worked. Tema degli esploratori: scienze della vita e salute (deposito sistematico; categoria «Immunology»). Fonte: Wikipedia in inglese, voce «ZMapp» — https://en.wikipedia.org/wiki/ZMapp Wikidata Q17486688 (dati Wikidata in CC0 1.0) — https://www.wikidata.org/wiki/Q17486688 Autori: i contributori di Wikipedia (cronologia: https://en.wikipedia.org/wiki/ZMapp?action=history). Licenza: Creative Commons Attribuzione-Condividi allo stesso modo 4.0 (CC BY-SA 4.0) — https://creativecommons.org/licenses/by-sa/4.0/. Il riuso richiede attribuzione e stessa licenza. Estratto dell'introduzione non modificato nel contenuto; revisione 1369645458, consultata il 2026-10-07T23:36:35.872Z tramite l'API ufficiale di Wikipedia. Impronta SHA-256 dell'estratto: 04d603b917c503d02b9198a9123c29358e434dec70c1e592a4d9795aa11ece45